Dolgit® gel
gel
![DolgitRR gel](javascript:obrazek_big("http://promedcs.cz//en/../img/baleni/600_dolgit_gel(1).jpg", "en"); "DolgitRR gel")
- Manufacturer:
- Dolorgiet Pharmaceuticals, St.Augustin/Bonn, Germany.
- Sole distributor for the Czech Republic:
- PRO.MED.CS Praha a.s.
- Marketing authorisation holder:
- Dolorgiet Pharmaceuticals, St.Augustin/Bonn, Germany.
- Composition:
- Ibuprofenum 5 g in 100 g of gel.
- Indication group:
- antirheumatic, antiphlogistic agent for topical administration
![DolgitRR gel](javascript:obrazek_big("http://promedcs.cz//en/../img/letaky/600_Dolgit - ikony pro GEL.jpg", "en"); "DolgitRR gel")
Characteristics:
Ibuprofen acts against pain and inflammation. Its effect is conditioned by suppression of the formation of prostaglandins and other mediators, which participate in the origin and development of these symptoms. Alleviation of pain, diminishing of edemas, and considerable improvement of the motility of the extremities take place already within half an hour.
Indications:
Dolgit® gel is intended for topical treatment of injuries of the locomotor system during sport activities or accidents, such as contusions, extravasation, sprain, dislocation, and muscular strain. When recommended by the physician, the preparation is used to treat acute or chronic inflammatory and painful pathological conditions of the locomotor system (inflammatory rheumatic diseases of the joints and spine, edemas or inflammations of the soft tissues adjacent to joints, e.g., bursas, tendons, tendon sheaths, ligaments, and joint capsules, in stiffness of the shoulder, muscular pains, lumbago, and in phlebitis (inflammation of veins). The preparation is intended for adults and children over 14 years of age.
Contraindications:
Dolgit® gel must not be used in patients with known hypersensitivity to ibuprofen, auxiliary substances and other anti-inflammatory agents (nonsteroidal antiphlogistics), which in the past was manifested by fits of asthma, urticaria, or cold. Dolgit® gel must not be applied to broken skin surface (open wounds or skin diseases) and mucous membranes. During the first and second thirds of pregnancy and in the period of lactation, the preparation can be administered only when recommended by the physician. On lactation, the preparation must not be applied to large areas for a long time, in the last third of pregnancy it is not administered at all. Dolgit® gel is not suitable for the treatment of children under 14 years of age.
Undesirable effects:
Dolgit® gel is usually well tolerated when applied to the skin. During treatment, manifestations of hypersensitivity to some component of the preparation may sporadically occur. It may be swelling and reddening of the skin, burning or itching sensation, sometimes dissemination of small pimples. In very rare cases, hypersensitivity reaction may develop in the form of breathlessness due to the narrowing of the bronchi. If these undesirable effects or any other unusual reactions occur, discontinue the treatment and consult your physician.
Interactions:
No interactions of topically administered ibuprofen with other drugs have been reported yet. Nevertheless, do not apply other topical preparations to the same spots without consulting your physician. Dosage and route of administration:
If not prescribed otherwise, a 4 to 10 cm long strip of gel is applied to the affected spot 3 to 4 times a day at 3 to 4 hour intervals and it is carefully rubbed in. On physician’s recommendation, penetration can be effectively enhanced by iontophoresis. In rheumatic diseases, the length of treatment is determined by the physician and 3 to 4 weeks are usually sufficient; in injuries during sport activities or an accident, 2 weeks. After applying Dolgit® gel to the affected spot, it is recommended to wash one’s hands (if the gel is not applied to the hands).
Caution:
Dolgit® gel contains isopropyl alcohol as an auxiliary substance, which may cause skin irritation. Gel administration is advisable also during general treatment with ibuprofen-containing tablets. The suitability of concomitant administration of Dolgit® gel with other drugs should be consulted with the physician. If in injuries the symptoms are not improved within 3 days, or they become even worse, or undesirable effects or some unusual reactions occur, consult the administration with your physician. Do not use the preparation longer than for 14 days without consulting your physician. If the preparation is accidentally swallowed by a child, consult the physician.
Package:
Aluminium tube containing 50 g of gel.
Carefully read the accompanying information before use.